H.C. Wainwright initiated coverage on Oyster Point Pharma with a new price target

7/18/22 7:31:49 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

H.C. Wainwright initiated coverage of Oyster Point Pharma with a rating of Buy and set a new price target of $20.00

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$OYST

Date	Price Target	Rating	Analyst
8/11/2022	$22.00	Buy	Chardan Capital Markets
7/18/2022	$20.00	Buy	H.C. Wainwright
11/9/2021	$30.00 → $23.00	Overweight → Neutral	JP Morgan